Ozogamicin
The term ozogamicin in the names of monoclonal antibodies or antibody-drug conjugates indicates that they are linked to a cytotoxic agent from the class of calicheamicins. See also *Gemtuzumab ozogamicin *Inotuzumab ozogamicin Inotuzumab ozogamicin, sold under the brand name Besponsa, is an antibody-drug conjugate medication used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The medication consists of a humanized monoclonal anti ... References {{Reflist Antibodies Antibody-drug conjugates ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]